White Paper: Outsourcing Insights

By Victor Coker, director of business intelligence, Nice Insight

If you have been in the pharmaceutical industry for an extended period of time, you've likely noticed how CROs have evolved from offering basic support to providing a wide range of clinical, central laboratory, and analytical services to meet market demands. Currently, the trend is for smaller CROs (as defined by revenue market share) to consolidate. Coupled with acquisitions, the organizations relied upon for independent development services are expanding and adding new services. As a result, the market is flooded with CROs that perform the same early-stage services, making it difficult for pharmaceutical and biotechnology companies to find the ideal candidates for their particular projects.

Used with permission from Life Science Leader magazine.